We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$196M
AUM Growth
+$16.9M
Cap. Flow
+$11.5M
Cap. Flow %
5.88%
Top 10 Hldgs %
45.53%
Holding
92
New
22
Increased
23
Reduced
22
Closed
6

Top Buys

Rank Stock Value
1
TPB icon
Turning Point Brands
TPB
+$3.38M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$1.73M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
4
IBB icon
iShares Biotechnology ETF
IBB
+$1.36M
5
SLV icon
iShares Silver Trust
SLV
+$1.14M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.53M
2
AMD icon
Advanced Micro Devices
AMD
+$1.49M
3
GLD icon
SPDR Gold Trust
GLD
+$1.17M
4
TBHC
The Brand House Collective
TBHC
+$954K
5
LOW icon
Lowe's Companies
LOW
+$770K

Sector Composition

Rank Sector Weight
1 Healthcare 35.09%
2 Technology 12.85%
3 Communication Services 9.63%
4 Financials 3.93%
5 Consumer Staples 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.1T
$852K 0.44%
4,000
-7,500
-65% -$1.53M
TGT icon
52
Target
TGT
$65.6B
$787K 0.4%
5,000
– –
GM icon
53
General Motors
GM
$80.4B
$740K 0.38%
+25,000
New +$702K
APTV icon
54
Aptiv
APTV
$12B
$688K 0.35%
7,500
-2,500
-25% -$210K
GEN icon
55
Gen Digital
GEN
$16.4B
$625K 0.32%
30,000
-10,000
-25% -$216K
VZ icon
56
CALL
Verizon
VZ
$195B
$595K 0.3%
+10,000
New +$581K
MU icon
57
CALL
Micron Technology
MU
$930B
$540K 0.28%
11,500
-13,500
-54% -$653K
NKTR icon
58
Nektar Therapeutics
NKTR
$2.39B
$528K 0.27%
2,120
-747
-26% -$235K
MSFT icon
59
Microsoft
MSFT
$3.45T
$526K 0.27%
2,500
– –
VXX icon
60
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
$498K 0.25%
+313
New +$556K
GDX icon
61
CALL
VanEck Gold Miners ETF
GDX
$22.7B
$490K 0.25%
12,500
-10,000
-44% -$408K
FCX icon
62
Freeport-McMoran
FCX
$90B
$469K 0.24%
+30,000
New +$433K
WBA
63
DELISTED
Walgreens Boots Alliance
WBA
$449K 0.23%
12,500
– –
NXPI icon
64
NXP Semiconductors
NXPI
$57.8B
$437K 0.22%
3,500
– –
MTNB icon
65
Matinas BioPharma
MTNB
$1.88M
$423K 0.22%
11,036
-240
-2% -$9.54K
REGN icon
66
CALL
Regeneron Pharmaceuticals
REGN
$78.5B
$392K 0.2%
+700
New +$424K
INTC icon
67
CALL
Intel
INTC
$455B
$388K 0.2%
+7,500
New +$390K
SGMO
68
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$382K 0.2%
40,400
-30,000
-43% -$324K
CLDR
69
DELISTED
Cloudera, Inc.
CLDR
$381K 0.19%
+35,000
New +$406K
NOK icon
70
CALL
Nokia
NOK
$51B
$338K 0.17%
86,500
– –
FCX icon
71
CALL
Freeport-McMoran
FCX
$90B
$313K 0.16%
+20,000
New +$289K
APTX
72
DELISTED
Aptinyx Inc. Common Stock
APTX
$310K 0.16%
91,800
-15,000
-14% -$57.5K
QCOM icon
73
Qualcomm
QCOM
$155B
$294K 0.15%
2,500
-2,500
-50% -$267K
B
74
CALL
Barrick Mining
B
$61.5B
$281K 0.14%
+10,000
New +$285K
OEF icon
75
CALL
iShares S&P 100 ETF
OEF
$20.1B
$271K 0.14%
+2,000
New +$308K
1 2
3
4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, DCF Advisers held 92 positions worth $196M, up 9.4% from $179M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

DCF Advisers deployed $11.5M of net new capital in Q3 2020, opening 22 new positions and adding to 23 existing holdings. Its largest new stake was iShares Biotechnology ETF: 10,000 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $1.53M trimmed.

  • DCF Advisers's largest Q3 2020 buy was iShares Biotechnology ETF: 10,000 shares worth $1.35M.
  • DCF Advisers added most to Turning Point Brands in Q3 2020, an estimated $3.38M increase.
  • DCF Advisers's biggest Q3 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $1.53M.
  • DCF Advisers's ten largest holdings make up 46% of its $196M portfolio in Q3 2020.
  • DCF Advisers opened 22 new positions and closed 6 in Q3 2020.
  • DCF Advisers's portfolio value rose 9.4% quarter-over-quarter to $196M.

Based on DCF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.